Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...

Bibliografske podrobnosti
Main Authors:	Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, Fatima O. Alsamani
Format:	Article
Jezik:	English
Izdano:	Elsevier 2022-01-01
Serija:	Informatics in Medicine Unlocked
Teme:	SARS-CoV-2 TMPRSS2 Fragment-based drug design Homology modeling Docking Molecular dynamics
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2352914822000247

Podobne knjige/članki

Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
od: Abdulrahim A. Alzain, PhD, et al.
Izdano: (2021-01-01)

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies
od: Fatima A. Elbadwi, et al.
Izdano: (2021-01-01)

Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
od: Mushtaq Hussain, et al.
Izdano: (2020-09-01)

Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
od: Ismail Hdoufane, et al.
Izdano: (2025-01-01)

Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19
od: Sergio Vazquez-Rodriguez, et al.
Izdano: (2023-01-01)

Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors
od: Mehdi Mahmudpour, et al.
Izdano: (2021-10-01)

TMPRSS2 Impacts Cytokine Expression in Murine Dendritic Cells
od: Sandra Gunne, et al.
Izdano: (2023-02-01)

The Important Role of TMPRSS2 Gene in Covid-19 and Prostate Cancer: In Silico Approach
od: Arif Kalkanli, et al.
Izdano: (2021-11-01)

Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach
od: Kailas D. Sonawane, et al.
Izdano: (2021-01-01)

<i>In Silico</i> Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility
od: Mohd Zulkifli Salleh, et al.
Izdano: (2022-02-01)

Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors
od: C. S. Sharanya, et al.
Izdano: (2024-07-01)

Detection of tmprss2-erg and tmprss2-egr1 gene fusion in prostate cancer from a Chinese population
od: Changqing Xu, et al.
Izdano: (2020-12-01)

In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
od: Shuo Wang, et al.
Izdano: (2022-06-01)

Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients
od: Laksmi Wulandari, et al.
Izdano: (2021-05-01)

Fragment-based virtual screening identifies novel leads against Plasmepsin IX (PlmIX) of Plasmodium falciparum: Homology modeling, molecular docking, and simulation approaches
od: Haider Thaer Abdulhameed Almuqdadi, et al.
Izdano: (2024-05-01)

In Silico Molecular Study of Tryptophan Bitterness
od: Antonella Di Pizio, et al.
Izdano: (2020-10-01)

Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening
od: Haviani Rizka Nurcahyaningtyas, et al.
Izdano: (2023-09-01)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
od: Anastasiya A. Kobelyatskaya, et al.
Izdano: (2021-06-01)

TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
od: Gilmara Barros de Lima, et al.
Izdano: (2025-01-01)

In silico molecular modeling and docking studies on the leishmanial tryparedoxin peroxidase
od: Ozal Mutlu
Izdano: (2014-04-01)

Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
od: Nazanin Zounemat Kermani, et al.
Izdano: (2021-01-01)

SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
od: Carlos D. Cruz-Hernández, et al.
Izdano: (2020-07-01)

The role of TMPRSS6/matriptase-2 in iron regulation and anemia
od: Chia-Yu eWang, et al.
Izdano: (2014-05-01)

ACE2 and TMPRSS2 genetic polymorphisms as potential predictors of COVID−19 severity and outcome in females
od: Sanja Matic, et al.
Izdano: (2024-12-01)

Publication trend of TMPRSS2 as SARS-CoV-2 receptor during the COVID-19 pandemic
od: Lalu Muhammad Irham, et al.
Izdano: (2023-03-01)

Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester
od: Bailey A. T. Weatherbee, et al.
Izdano: (2020-08-01)

Optimization of East Java Propolis Extraction as Anti SARS-Cov-2 by Molecular Docking Study
od: Sofia Aulia Hidayat, et al.
Izdano: (2022-07-01)

ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder
od: Gi-Cheol Park, et al.
Izdano: (2022-04-01)

Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers
od: Karthikeyan Subbarayan, et al.
Izdano: (2025-03-01)

Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach
od: Minh-Tri Le, et al.
Izdano: (2021-05-01)

Salivary ACE2 and TMPRSS2 link to periodontal status and metabolic parameters
od: Dan Zhao, et al.
Izdano: (2022-03-01)

Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies
od: Linda M. Mohamed, et al.
Izdano: (2022-07-01)

A Polymorphism in the TMPRSS2 Gene Increases the Risk of Death in Older Patients Hospitalized with COVID-19
od: Clara Caldeira de Andrade, et al.
Izdano: (2022-11-01)

Improved Zika virus plaque assay using Vero/TMPRSS2 cell line
od: Olukunle O. Oluwasemowo, et al.
Izdano: (2025-01-01)

Molecular Characterization of TMPRSS2-ERG Gene Fusion in the NCI-H660 Prostate Cancer Cell Line: A New Perspective for an Old Model
od: Kirsten D. Mertz, et al.
Izdano: (2007-03-01)

ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
od: Akçahan GEPDİREMEN, et al.
Izdano: (2020-12-01)

Hydrogen Sulfide Inhibits TMPRSS2 in Human Airway Epithelial Cells: Implications for SARS-CoV-2 Infection
od: Giulia Pozzi, et al.
Izdano: (2021-09-01)

Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis
od: Debasmita Mukhopadhyay, et al.
Izdano: (2020-09-01)

TMPRSS2 gene, single nucleotide polymorphism rs8134378, single nucleotide polymorphism rs12329760.
od: Majd Aljamali, et al.
Izdano: (2023-04-01)

<it>TMPRSS2-ERG </it>-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
od: Brase Jan C, et al.
Izdano: (2011-12-01)